|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00004815 |
|
Date of registration:
|
24/02/2000 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
May 1992 |
|
Target sample size:
|
1 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00004815 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Contacts
|
|
Name:
|
Craig D. Rubin |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Texas |
| | |
|
Key inclusion & exclusion criteria
|
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics-- Werner's syndrome with osteoporosis and low serum insulin-like
growth factor 1 level Patient treated on protocol 04-9215300 "Metabolic and Skeletal
Effects of Exogenous Recombinant Human Insulin-Like Growth Factor"
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Werner's Syndrome
|
|
Intervention(s)
|
|
Drug: growth hormone
|
|
Secondary ID(s)
|
|
UTSMC-49215300
|
|
199/12024
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|